The year ahead in pharma
Pf Magazine January 2018
Latest articles
NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
Amanda Pritchard appointed new Chief Executive Officer of NHS England
The first woman to lead NHS England, Amanda Pritchard, has been appointed and will take up her post on Sunday August 1. She takes...
Study shows AZ’s COVID-19 vaccine did not increase rate of rare blood clots after...
Data published in The Lancet has demonstrated that AstraZeneca’s COVID-19 jab Vaxzevria (formerly AZD1222) does not increase the rate of rare blood clots after...
Popular articles
NICE recommendation for UCB’s bimekizumab as treatment for severe plaque psoriasis
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination, recommending UCB’s bimekizumab as an option for the treatment...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
ABPI Code & digital content myth-busting
Dr Rina Newton busts some myths to demonstrate the commercial wins when ABPI code compliance is not considered digital content’s arch nemesis. Top ten takeaways
1....
Negotiating the changing NHS landscape: five critical shifts the pharma industry must embrace
As the long-awaited Health and Care Bill begins its passage through parliament, Oli Hudson looks at five critical changes resulting from these reforms that...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...